An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma

Study ID
NCT02576509

Study type
Interventional

Study phase
Phase 3

Study status
Completed

Trial Acronym

Trial Summary

The purpose of this study is to determine if nivolumab or sorafenib is more effective in the treatment of Advanced Hepatocellular Carcinoma.

More informations

Trial Starting Date

Dec 07,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

743